Inj, clindamycin (baxter)
Products billed under this code include Clindamycin Phosphate.
Payment limit per 300 MG, by effective quarter, 4Q23 to 4Q26. Gaps mean the code was not in that quarter’s file, or CMS gave no payment limit.Products billed under this code include Clindamycin Phosphate.
Payment limit per 300 MG, by effective quarter, 4Q23 to 4Q26. Gaps mean the code was not in that quarter’s file, or CMS gave no payment limit.From the 4Q26 NDC–HCPCS crosswalk. “Limit / pkg” is the 4Q26 payment limit times the billing units in one package.
| Product | Labeler | NDC | Units / pkg | Limit / pkg |
|---|---|---|---|---|
| Clindamycin Phosphate | Baxter Healthcare Corporation | 00338-9545-24 | 24 | $49.632 |
| Clindamycin Phosphate | Baxter Healthcare Corporation | 00338-9549-24 | 48 | $99.264 |
| Clindamycin Phosphate | Baxter Healthcare Corporation | 00338-9553-24 | 72 | $148.896 |
| Quarter | Payment limit | Change | Billing unit | Description | Source file |
|---|---|---|---|---|---|
| 4Q26 | $2.068 | −$0.118 | 300 MG | Inj, clindamycin (baxter) | v1, posted September 17, 2026 |
| 3Q26 | $2.186 | −$0.138 | 300 MG | Inj, clindamycin (baxter) | v1, posted September 15, 2026 |
| 2Q26 | $2.324 | −$0.022 | 300 MG | Inj, clindamycin (baxter) | v1, posted September 15, 2026 |
| 1Q26 | $2.346 | +$0.138 | 300 MG | Inj, clindamycin (baxter) | v1, posted September 15, 2026 |
| 4Q25 | $2.208 | +$0.491 | 300 MG | Inj, clindamycin (baxter) | v1, posted September 8, 2026 |
| 3Q25 | $1.717 | −$0.81 | 300 MG | Inj, clindamycin (baxter) | v1, posted March 10, 2026 |
| 2Q25 | $2.527 | −$0.078 | 300 MG | Inj, clindamycin (baxter) | v1, posted March 10, 2026 |
| 1Q25 | $2.605 | −$0.21 | 300 MG | Inj, clindamycin (baxter) | v1, posted December 19, 2025 |
| 4Q24 | $2.815 | −$0.449 | 300 MG | Inj, clindamycin (baxter) | v1, posted June 11, 2025 |
| 3Q24 | $3.264 | +$1.057 | 300 MG | Inj, clindamycin (baxter) | v1, posted June 11, 2025 |
| 2Q24 | $2.207 | +$0.456 | 300 MG | Inj, clindamycin (baxter) | v1, posted March 11, 2025 |
| 1Q24 | $1.751 | −$0.843 | 300 MG | Inj, clindamycin (baxter) | v1, posted December 19, 2024 |
| 4Q23 | $2.594 | – | 300 MG | Inj, clindamycin (baxter) | v1, posted October 10, 2024 |
“Change” is the difference from the previous quarter, shown only when both quarters have a payment limit and the billing unit is the same. “vs. last quarter” and “vs. a year ago” follow the same rule.